Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Leveraging the Oxford Nanopore MinION sequencing platform for HIV-1 drug resistance surveillance in resource-limited settings: a post-COVID implementation opportunity.

Virology journal - 15 Mar 2026

Washaya Tendai, Chimukangara Benjamin, Mayini Justin, Bote Sandra, Chin'ombe Nyasha, Munyati Shungu, Manasa Justen

Abstract excerpt

BACKGROUND: HIV drug resistance (HIVDR) testing remains essential for optimizing antiretroviral therapy (ART), yet access remains constrained by high cost, low throughput, and limited availability of Sanger sequencing in resource-limited settings (RLS). Recent improvements in Oxford Nanopore Technologies (ONT) sequencing offer a potential alternative, especially following the expansion of genomic surveillance...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-HIV Agents
Share to COVID-19

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Resistance, Viral

Share to Genotyping Techniques

Share to HIV Integrase

Share to HIV Protease

Share to HIV Reverse Transcriptase

Share to Nanopore Sequencing

Source

Open in PubMed Open full text

Identifiers

PMID: 41832510
DOI: 10.1186/s12985-026-03134-0
PMCID: PMC13104186

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Leveraging the Oxford Nanopore MinION sequencing platform for HIV-1 drug resistance surveillance in resource-limited settings: a post-COVID implementation opportunity.PMID 41832510Read ↗

The utility of integrating nanopore sequencing into routine HIV-1 drug resistance surveillance.Semantic proximity Read ↗

Portable Nanopore sequencing solution for next-generation HIV drug resistance testing.Semantic proximity Read ↗

Barcoding analysis of HIV drug resistance mutations using Oxford Nanopore MinION (ONT) sequencingSemantic proximity Read ↗

Nano-RECall provides an integrated pipeline for HIV-1 drug resistance testing from Oxford Nanopore sequence data.Semantic proximity Read ↗

Population-based nanopore sequencing of the HIV-1 pangenome to identify drug resistance mutations.Semantic proximity Read ↗

Rapid and economical drug resistance profiling with Nanopore MinION for clinical specimens with low bacillary burden of Mycobacterium tuberculosisSemantic proximity Read ↗

HIV-1 Drug Resistance Assay Using Ion Torrent Next Generation Sequencing and On-Instrument End-to-End Analysis Software.Semantic proximity Read ↗

HIV-DRIVES: HIV Drug Resistance Identification, Variant Evaluation, & Surveillance PipelineSemantic proximity Read ↗

HIV-1 Drug Resistance Genotyping in Resource Limited Settings: Current and Future Perspectives in Sequencing Technologies.Semantic proximity Read ↗

Deep sequencing for HIV-1 clinical management.Semantic proximity Read ↗

G-HIV: An Integrated Long-Read Sequencing and Automated Bioinformatics Platform for Rapid and Precise HIV-1 SurveillanceSemantic proximity Read ↗

HIV-DRIVES: HIV Drug Resistance Identification, Variant Evaluation, & Surveillance PipelineSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.